SCHEMBL19475100

SCHEMBL19475100

N#Cc1c(NC(=O)c2c(F)c(F)c(F)c(F)c2F)sc2c1CCOC2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 4/20 0.48
ANO1 Q5XXA6 1/20 0.46
PTPRC P08575 1/20 0.45
PTPN2 P17706 1/20 0.45
PTPN1 P18031 1/20 0.45
PTPRB P23467 1/20 0.45
PTPRE P23469 1/20 0.45
POLB P06746 1/20 0.45
ALDH1A1 P00352 6/20 0.45
NPC1 O15118 5/20 0.45
RAB9A P51151 4/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
HPGD P15428 3/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
LMNA P02545 1/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
GAA P10253 2/20 0.44
KDM4E B2RXH2 1/20 0.44
THRB P10828 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19475104 0.81 CFTR (0.65) ANO1PTPRCPTPN2PTPN1PTPRB
SCHEMBL6250301 0.79 MEN1 (0.56) POLBALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL2643514 0.75 ALDH1A1 (0.52) MAPK10POLBALDH1A1NPC1RAB9A
SCHEMBL19475093 0.75 ALDH1A1 (0.52) ANO1ALDH1A1SMN1; SMN2HPGDL3MBTL1
SCHEMBL20915159 0.74 ALDH1A1 (0.60) POLBALDH1A1SMN1; SMN2HPGDL3MBTL1
SCHEMBL618553 0.74 ALDH1A1 (0.59) MAPK10POLBALDH1A1NPC1RAB9A
SCHEMBL2643860 0.71 GCGR (0.49) MAPK10POLBALDH1A1NPC1RAB9A
SCHEMBL5467114 0.66 CFTR (0.64) ANO1NPC1RAB9AMEN1KMT2A
SCHEMBL621181 0.66 BPTF (0.59) POLBALDH1A1SMN1; SMN2HPGDL3MBTL1
SCHEMBL3279132 0.65 MAPK10 (0.77) MAPK10POLBALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10647725-B2 Anti-infective 2-aminothiophenes THE UNIVERSITY OF TOLEDO (US) 2020-05-12 US disclosed
US-10647725-B2 Anti-infective 2-aminothiophenes THE UNIVERSITY OF TOLEDO (US) 2020-05-12 US disclosed
US-20190119296-A1 Anti-Infective 2-Aminothiophenes THE UNIVERSITY OF TOLEDO (US) 2019-04-25 US disclosed
US-20190119296-A1 Anti-Infective 2-Aminothiophenes THE UNIVERSITY OF TOLEDO (US) 2019-04-25 US disclosed
WO-2017184947-A1 ANTI-INFECTIVE 2-AMINOTHIOPHENES THE UNIVERSITY OF TOLEDO (US) 2017-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190119296-A1 Anti-Infective 2-Aminothiophenes TST, ABAT, TPMT MAPK10 3880/4885ANO1 3263/4885PTPRC 2522/4885
US-10647725-B2 Anti-infective 2-aminothiophenes TST, ABAT, TPMT MAPK10 3880/4885ANO1 3263/4885PTPRC 2522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.